Value Star Asset Management (Hong Kong) LTD I Mab Call Options Transaction History

Value Star Asset Management (Hong Kong) LTD

$290 Million
Q1 2024

Call Options

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2021 Nov 09, 2021	SELL	$57.18 - $84.43 $857,700 - $1.27 Million	-15,000 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$47.86 - $83.95 $717,900 - $1.26 Million	15,000 New	15,000 $1.26 Million

Others Institutions Holding IMAB

# of Institutions

Shares Held

16M

Call Options Held

11.9K

Put Options Held

3.5K

Hhlr Advisors, Ltd. Grand Cayman, E9

6.91M
Shares

$10.8 Million
0.29% of portfolio
Decheng Capital Management Iii (Cayman), LLC

4.17M
Shares

$6.5 Million
3.04% of portfolio
David A. Siegel Two Sigma Advisers, LP | New York, Ny

617K
Shares

$962,676
0.0% of portfolio
Two Sigma Investments, LP New York, NY

576K
Shares

$897,904
0.0% of portfolio
Temasek Holdings (Private) LTD Singapore, U0

567K
Shares

$883,974
0.01% of portfolio

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $130M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Value Star Asset Management (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Value Star Asset Management (Hong Kong) LTD with notifications on news.

Account